Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2009

01-06-2009 | Guidelines

Chapter 23. Treatment of hyperkalemia and metabolic acidosis

Published in: Clinical and Experimental Nephrology | Issue 3/2009

Login to get access

Excerpt

Table 23-1
Emergency treatment of hyperkalemia: CKD stage 3 and over
Measures
Effect
Example of the treatment
Ca gluconate, iv
Cardiac protection
Ca gluconate 10 mL, 5 min, iv
Loop diuretics, iv
Increase the urinary excretion
Furosemide 20 mg + saline 20 mL
NaHCO3
Shift into cells
7% NaHCO3 20 mL, iv
Glucose-insulin
Shift into cells
10 g of glucose with 1 unit insulin, div. No glucose if hyperglycemia
Cation exchanger resin
Removal
30 g, dissolved in 100 mL warm water, then given into rectum, and left for 1 h
Hemodialysis
Removal
3 h or longer depending on the plasma K
  • As CKD stage progresses, metabolic acidosis develops and serum potassium (K) increases.
  • In case of severe hyperkalemia, ECG recording should be performed to evaluate the emergency.
  • A hyperkalemic patient with abnormal ECG findings should be treated as emergency and be consulted with nephrologists thereafter.
  • The causes of hyperkalemia in CKD are mainly due to drugs such as ACE inhibitors, ARBs, spironolactone, etc. and to excess of potassium-rich diet (Table 23-1).
Metadata
Title
Chapter 23. Treatment of hyperkalemia and metabolic acidosis
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0155-9

Other articles of this Issue 3/2009

Clinical and Experimental Nephrology 3/2009 Go to the issue